Scilex Holding Co | - | 4.24% | - | - | 0 |
Alnylam Pharmaceuticals Inc | - | 0.00% | - | - | 0 |
Arbutus Biopharma Corp | - | 0.00% | - | - | 0 |
Arcturus Therapeutics Holdings Inc | - | 0.00% | - | - | 0 |
Arrowhead Pharmaceuticals Inc | - | 0.00% | - | - | 0 |
Avidity Biosciences Inc Ordinary Shares | - | 0.00% | - | - | 0 |
BeiGene Ltd ADR | - | 0.00% | - | - | 0 |
BioNTech SE ADR | - | 0.00% | - | - | 0 |
Dyne Therapeutics Inc Ordinary Shares | - | 0.00% | - | - | 0 |
Gritstone Bio Inc | - | 0.00% | - | - | 0 |
As of April 27, 2023, Direxion Shares ETF Trust - Direxion mRNA ETF has gone out of business. Direxion Shares ETF Trust - Direxion mRNA ETF is an exchange traded fund launched by Direxion Investments. The fund is managed by Rafferty Asset Management, LLC. It invests in public equity markets of global region. The fund invests in stocks of companies operating across development and application of messenger RNA or the mRNA technology sectors. It invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to track the performance of the BITA Messenger RNA Technology Index, by using full replication technique. Direxion Shares ETF Trust - Direxion mRNA ETF was formed on December 9, 2021 and is domiciled in the United States.